Live Breaking News & Updates on Makoto Suematsu

Stay updated with breaking news from Makoto suematsu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ALS Breakthrough – Parkinson's Drug Safely Slows Disease Progression by Over 6 Months

ALS Breakthrough – Parkinson's Drug Safely Slows Disease Progression by Over 6 Months
scitechdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scitechdaily.com Daily Mail and Mail on Sunday newspapers.

Hideyuki Okano , Masaki Takao , Miwa Hirai , Masashi Aoki , Tosho Kondo , Naoki Suzuki , Lou Gehrig , Satoru Morimoto , Daisuke Ito , Makoto Suematsu , Shiho Nakamura , Kensuke Okada , Koki Fujimori , Yuto Fujiki , Shinichi Takahashi , Yasuaki Kabe , Ayumi Nishiyama , Chris Kato , Fumiko Ozawa , Masahiro Jinzaki , Keio University Hospital , Okasan Kato Foundation Research Grant , Japan Agency For Medical Research , Keio University School Of Medicine , National Centre Of Neurology , Japan Society For The Promotion Of Science ,

Japan Hit Hard by COVID After Skimping on Disease Research

Japan Hit Hard by COVID After Skimping on Disease Research
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , South Korea , Hiroaki Kitano , Makoto Suematsu , Norio Ohmagari , Masanori Fukushima , Technology Graduate School , Health Society Institute , Centre For Prevention , Professor At Okinawa Institute Of Science , Professor Emeritus At Kyoto University , Global Health , Sony Computer Science Laboratories Inc , Japan National Center , Digital Science , Nature Index , Disease Control , National Center , Emerging Infectious , Keio University , Professor Hiroaki Kitano , Sony Computer Science Laboratories , Okinawa Institute , Representative Director , Learning Health Society Institute , Professor Emeritus ,

Harnessing Brain's Plasticity to Acquire Epilepsy Resilience

Around 1% of the world’s population lives with epilepsy; yet only 65% of epilepsy patients can manage their symptoms with medication. Currently ....

Yuki Sugiura , Yoko Ikoma , Yoshiteru Shimoda , Satoshi Zuguchi , Ryutaro Yano , Makoto Suematsu , Ko Matsui , Hajime Mushiake , Satoru Moritoh , Nobukazu Nakasato , Masaki Iwasaki , Utaro Hino , Yosukem Morizawa , Kaoru Beppu , Kenjif Tanaka , Teiji Tominaga , Brain Physiology Lab At Tohoku University , Super Network Brain Physiology Lab , Tohoku University , Yugo Fukazawa ,

Weaker virus strain might be treatable with drug for cats : The Asahi Shimbun

The possibility has emerged of using a drug developed for cats to treat COVID-19 in humans. (Asahi Shimbun file photo)
A research team in Japan identified a variant strain of the novel coronavirus that it says might be treatable with a drug developed to treat cats with the disease due to its weakness.
The researchers from Tokyo’s Keio University and Osaka University confirmed the strain leads to comparatively minor symptoms in humans.
An antivirus drug known as GC376 has been developed abroad that has been used to treat feline infectious peritonitis, a fatal disease caused by a novel coronavirus in cats. ....

United Kingdom , Shigeko Segawa , Makoto Suematsu , Kenji Tamura , Osaka University , Keio University Hospital , Tokyo Keio University , Keio University , Japan News , Sci Tech , Asahi Shimbun , ஒன்றுபட்டது கிஂக்டம் , கெஞ்சி தமுரா , ஒசகக பல்கலைக்கழகம் , கேோ பல்கலைக்கழகம் மருத்துவமனை , டோக்கியோ கேோ பல்கலைக்கழகம் , கேோ பல்கலைக்கழகம் , ஜப்பான் செய்தி , அறிவியல் தொழில்நுட்பம் , ஆசாஹி ஶிஂபந் ,